Solventum Corporation (SOLV)
SOLV trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$86.30
+1.16% on the day
Market cap
$14.7B
Large cap
Revenue · 2025
$8.3B
+0.9% on 2024
Net income · 2025
$1.6B
18.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SOLV on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001964738 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $8.3B |
| Net income | $1.6B |
| Operating income | $2.2B |
| Net margin | 18.7% |
| Operating margin | 26.2% |
| Revenue growth | +0.9% |
| Cash | $878.0M |
| Total assets | $14.3B |
| P/E (computed) | 9.4× |
| P/S (computed) | 1.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B7 | 2025-08-14 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-03-27 |
Source: SEC EDGAR submissions feed, 261 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +1.4% |
| 1 month | -3.3% |
| 3 months | +6.6% |
| Year to date | +9.9% |
| 1 year | +22.9% |
| From 52-week high | -5.8% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BAX | Baxter International Inc. | $24.89 | +0.44% | $12.9B |
| PEN | Penumbra Inc. | $320.01 | -0.30% | $12.6B |
| GMED | Globus Medical Inc. | $76.32 | +0.10% | $10.2B |
| GKOS | Glaukos Corporation | $165.50 | -1.50% | $9.8B |
| PODD | Insulet Corporation | $138.13 | -1.20% | $9.6B |
| WST | West Pharmaceutical Services Inc. | $371.82 | +1.15% | $26.2B |
| DXCM | DexCom Inc. | $85.06 | -1.00% | $32.1B |
| RMD | ResMed Inc. | $235.04 | +0.19% | $33.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier